Research Article

Unraveling the Role of Apoptosis in the Antiproliferative Activity of β-Glucan on A549 Cells

Volume: 44 Number: 4 December 28, 2023
EN

Unraveling the Role of Apoptosis in the Antiproliferative Activity of β-Glucan on A549 Cells

Abstract

Previous studies have reported the anticancer properties of β-glucan on various cancer cells. The objective of this research was to investigate the involvement of apoptosis in the cytotoxic action of β-glucan on the A549 cells. The cytotoxic impact of this drug on A549 cells was examined by subjecting them to various quantities of the substance, and the XTT assay was utilized to determine cell survival. Flow cytometry was performed to investigate apoptosis. A statistically significant and dose-dependent cytotoxic impact on A549 cells was observed upon treatment with β-glucan. The calculated IC50 value of β-glucan for A549 cells after a 24-hour treatment period was discovered to be 82.16 μg/mL. Further investigations carried out using the IC50 dose of β-glucan revealed a significant increase in the late apoptotic cells percentage. The capacity of β-glucan to trigger apoptosis is thought to be the cause of its cytotoxic action on lung cancer. The revelation of this discovery emphasizes the promising possibilities of β-glucan as an effective therapeutic choice.

Keywords

Thanks

Acknowledgments: The 1Sivas 1Cumhuriyet University, 1School of Medicine, 1CUTFAM Research Center, Sivas, 1Turkey, provided the necessary tools and infrastructure 1for the execution of this examination, for which the authors are grateful.

References

  1. [1] Roudi R., Mohammadi S.R., Roudbary M, Mohsenzadegan M., Lung cancer and β-glucans: review of potential therapeutic applications, Investigational New Drugs, 35 (2017) 509–17.
  2. [2] Peymaeei F., Sadeghi F., Safari E., Khorrami S., Falahati M., Mohammadi S.R., et al., Candida albicans Beta-Glucan Induce Anti- Cancer Activity of Mesenchymal Stem Cells against Lung Cancer Cell Line: An In-Vitro Experimental Study, Asian Pacific Journal of Cancer Prevention, 21 (2020) 837.
  3. [3] Koparal A.T., Zeytinoglu M., Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549, Cytotechnology, 43 (2003) 149–54.
  4. [4] Tong X., Tang R., Xiao M., Xu J., Wang W., Zhang B., et al., Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research, Journal of Hematology & Oncology, 15 (2022) 1–32.
  5. [5] Castro-Cruz A., Echeverría O.M., Juárez-Chavero S., Sánchez-Sánchez L., Torres-Ramírez N., Vázquez-Nin G.H., et al., Transcriptional activity and splicing factors are preserved during physiological apoptosis, Journal of Structural Biology, 214 (2022) 107884.
  6. [6] Liu Y., Chen Y., Lin L., Li H., Gambogic acid as a candidate for cancer therapy: A review, International Journal of Nanomedicine, 15 (2020) 10385–99.
  7. [7] Thomas S., Rezoagli E., Abidin I.Z., Major I., Murray P., Murphy E.J., β-Glucans from Yeast—Immunomodulators from Novel Waste Resources, Applied Sciences, 12 (2022) 5208.
  8. [8] Karimi R., Homayoonfal M., Malekjani N., Kharazmi M.S., Jafari S.M., Interaction between β-glucans and gut microbiota: a comprehensive review, Critical Reviews in Food Science and Nutrition, (2023) 1-32.

Details

Primary Language

English

Subjects

Basic Pharmacology

Journal Section

Research Article

Publication Date

December 28, 2023

Submission Date

August 1, 2023

Acceptance Date

December 2, 2023

Published in Issue

Year 2023 Volume: 44 Number: 4

APA
Joha, Z., & Ergül, M. (2023). Unraveling the Role of Apoptosis in the Antiproliferative Activity of β-Glucan on A549 Cells. Cumhuriyet Science Journal, 44(4), 640-644. https://doi.org/10.17776/csj.1336167

Cited By

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December